MeMed Overview
- Year Founded
-
2009
- Status
-
Private
- Employees
-
100
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$12M
- Investors
-
24
MeMed General Information
Description
Developer of immuno-personalized diagnosis devices designed to detect bacterial and viral infections. The company's devices distinguish between bacterial and viral infections based on patients' immune responses to different infection types, enabling physicians to get rapid and actionable clinical information that guides them to make informed antibiotic treatment decisions.
Contact Information
Website
www.me-med.comCorporate Office
- 7 Nahum Het Street
- Park High-Tech North
- Tirat Carmel 3508506
- Israel
Corporate Office
- 7 Nahum Het Street
- Park High-Tech North
- Tirat Carmel 3508506
- Israel
MeMed Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Grant | 12-Jan-2026 | $12M | Completed | Generating Revenue | ||
| 11. Later Stage VC (Series E) | 01-Jul-2021 | Completed | Generating Revenue | |||
| 10. Grant | 13-Nov-2019 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series D) | 01-Jul-2018 | Completed | Generating Revenue | |||
| 8. Grant | 01-Sep-2017 | Completed | Generating Revenue | |||
| 7. Debt - General | Completed | Generating Revenue | ||||
| 6. Grant | 08-Sep-2016 | Completed | Generating Revenue | |||
| 5. Grant | 23-Jul-2015 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series B) | 01-Jan-2015 | $23.8M | $32.5M | Completed | Generating Revenue | |
| 3. Grant | 14-Nov-2013 | $8.15M | $8.67M | Completed | Startup |
MeMed Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Preferred D | ||||||||
| Preferred C | ||||||||
| Preferred B2 | ||||||||
| Preferred B1 | ||||||||
| Preferred A2 | 407,790 | $0.010000 | $4.95 | $4.95 | 1x | $4.95 | 14.46% | |
| Preferred A1 | 145,800 | $0.010000 | $2.4 | $2.4 | 1x | $2.4 | 5.17% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
MeMed Comparisons
Industry
Financing
Details
MeMed Competitors (2)
One of MeMed’s 2 competitors is Biocartis, a Venture Capital-Backed company based in Mechelen, Belgium.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Biocartis | Venture Capital-Backed | Mechelen, Belgium | ||||
| BioFire | Venture Capital-Backed | Salt Lake City, UT |
MeMed Patents
MeMed Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026069328-A1 | Markers for diagnosing infections | Pending | 26-Sep-2024 | ||
| WO-2026069329-A1 | Markers for predicting severity | Pending | 26-Sep-2024 | ||
| EP-4558829-A1 | Markers for diagnosing infections | Pending | 20-Jul-2022 | ||
| EP-4558829-A4 | Markers for diagnosing infections | Pending | 20-Jul-2022 | ||
| US-20260029409-A1 | Markers for diagnosing infections | Pending | 20-Jul-2022 | G01N33/6893 |
MeMed Signals
MeMed Investors (24)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Innovation Authority | Government | |||
| Frog Design | Venture Capital | Minority | ||
| La Maison Partners | Venture Capital | Minority | ||
| Ping An Voyager Partners | Venture Capital | Minority | ||
| Poalim Equity | PE/Buyout | Minority |
MeMed FAQs
-
When was MeMed founded?
MeMed was founded in 2009.
-
Where is MeMed headquartered?
MeMed is headquartered in Tirat Carmel, Israel.
-
What is the size of MeMed?
MeMed has 100 total employees.
-
What industry is MeMed in?
MeMed’s primary industry is Diagnostic Equipment.
-
Is MeMed a private or public company?
MeMed is a Private company.
-
What is MeMed’s current revenue?
The current revenue for MeMed is .
-
How much funding has MeMed raised over time?
MeMed has raised $195M.
-
Who are MeMed’s investors?
Innovation Authority, Frog Design, La Maison Partners, Ping An Voyager Partners, and Poalim Equity are 5 of 24 investors who have invested in MeMed.
-
Who are MeMed’s competitors?
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process